CGAS and neoplasm: Given ongoing efforts to develop selective inhibitors of cGAS, STING33,52 and ER stress sensors, such as PERK53, our work offers an exciting opportunity for therapeutic intervention in chromosomally unstable tumours for which there are currently few effective therapeutic options.